Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR2, also known as CD192, is a G protein-coupled receptor that serves as a high-affinity receptor for several chemokines, most notably CCL2 (MCP-1). It plays critical roles in the immune system and inflammatory processes, particularly in monocyte chemotaxis and migration to inflammatory sites. CCR2 is implicated in various pathological conditions, including inflammatory diseases, liver pathology, cardiovascular disease, neurodegenerative disorders, and metabolic disorders. Due to its involvement in these disease processes, CCR2 has emerged as a potential therapeutic target.
Inhibition of CCL2/CCR2 axis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C Motif Chemokine Receptor 2 (CCR2).